---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-159289"
form_type: "8-K"
ticker: "RVMD"
cik: "0001628171"
company_name: "Revolution Medicines, Inc."
filed_at: "2026-04-16T23:59:59+00:00"
generated_at: "2026-05-15T05:47:11.160823+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Revolution Medicines raises ~$2.15B via equity and convertible note offerings

## Summary
- Equity offering: 10,563,381 shares at $142/sh + full over-allotment of 1,584,506 shares; net proceeds ~$1.65B.
- Convertible note offering: $500M aggregate principal of 0.50% Convertible Senior Notes due 2033.
- Equity closed April 16; note offering expected to close April 17; underwriters J.P. Morgan, TD Securities, Guggenheim.

## SEC filing metadata
- accession: 0001193125-26-159289
- form_type: 8-K
- ticker: RVMD
- cik: 0001628171
- company_name: Revolution Medicines, Inc.
- filed_at: 2026-04-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628171/000119312526159289/0001193125-26-159289-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628171/000119312526159289/d95226d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-159289
- JSON: https://secwatch.observer/filing/0001193125-26-159289.json
- Plain text: https://secwatch.observer/filing/0001193125-26-159289.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.